By Tina Reed
More than 1,700 healthcare workers have died of COVID-19 since the pandemic began, according to a new report from one of the largest nurses' unions in the country.
read more
By Ben Adams
Johnson & Johnson has posted an early peek at its phase 1/2 trial data for its pandemic vaccine hopeful that last week started late-stage tests.
read more
By Beth Snyder Bulik
A massive ad campaign designed to quell Americans’ coronavirus fears before the November election faced new criticism as details about the $300 million effort leaked. B-list celebrity involvement, funding shenanigans and political undertones raise “every red flag I could dream of," one ex-HHS official told Politico.
read more
By Eric Sagonowsky, Angus Liu, Kyle Blankenship, Conor Hale, Fraiser Kansteiner
The FDA hit Inovio's phase 2/3 vaccine trial with a partial hold. Covaxx kicked off a phase 1 trial of its multitope vaccine hopeful in Taiwan. CapsoVision got the OK to market its endoscope pill for home use during the pandemic. Plus, Warp Speed has more military officials at the helm than civilian scientists, Stat reported.
read more
By Healthcare Staff
Follow along with the latest COVID-19 news straight from the Fierce Healthcare team.
read more
By Tina Reed
The poll results come amid growing concerns of new surges in COVID-19 cases just as the U.S. heads into the fall season when influenza cases traditionally pick up.
read more
By Amirah Al Idrus
The FDA slapped a partial clinical hold on the phase 2/3 study of Inovio’s COVID-19 vaccine because it has “additional questions” about the trial, the company revealed on Monday. The hold is not a response to side effects seen in a phase 1 study of the vaccine and so, will not affect that trial, nor any of Inovio's other work.
read more
By Ben Adams
Whilst COVID-19 consumes our minds and the current budgets of the world, cancer will still develop and kill; genetic abnormalities will create rare diseases with no treatment; millions will still die from influenza. This year, we’ve chosen from a diverse range of those fighting COVID, as well as those fighting longer term plagues against our biology.
read more
By Ben Adams
Oligonucleotide-focused biotech Aligos Therapeutics is shooting for a $100 million IPO to help drive its early work on a functional cure for chronic hepatitis B as well as COVID-19.
read more
By Conor Hale
CapsoVision—maker of an ingestible camera pill for scanning the inside of a person’s gastrointestinal tract—has received word from the FDA that they may offer their device for fully remote, at-home use during the COVID-19 pandemic.
read more
